Tag: National Institutes of Health
Vaxxas to develop first room-temperature stable RSV vaccine with NIH license
Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV).
3D-printed skin technology offers hope for wound healing and hair restoration
A recent breakthrough in 3D bioprinting technology has paved the way for the creation of multi-layered living skin with the potential to regenerate hair follicles.
MIT researchers develop 3D-printed heart that functions like a real one
Engineers at the Massachusetts Institute of Technology have devised a method for 3D printing a soft and flexible replica of a patient's heart in the hopes of helping doctors tailor treatments to patients’ specific heart form and function.
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
